Electroconvulsive therapy in catatonic patients: Efficacy and predictors of response. [PDF]
Luchini F +5 more
europepmc +1 more source
Parkinson's Disease: From Pathogenesis to Pharmacogenomics. [PDF]
Cacabelos R.
europepmc +1 more source
[The use of neuromodulation for the treatment of tremor]. [PDF]
Bendersky D, Ajler P, Yampolsky C.
europepmc +1 more source
Peripartum cardiomyopathy management: insights from a Latin American case report. [PDF]
Torres-Valencia J +4 more
europepmc +1 more source
A systematic review on clinical management of antipsychotic-induced sexual dysfunction in schizophrenia. [PDF]
Costa AM, Lima MS, Mari Jde J.
europepmc +1 more source
[Use of ultrasound in vein of Galen malformation]. [PDF]
De La Rosa-Alamilla M +2 more
europepmc +1 more source
Selective and extremely long inhibition of prolactin release in man by 1-ethyl-3-(3'-dimethylaminopropyl)-3-(6'-allylergoline-8'-beta- carbonyl)-urea-diphosphate (FCE 21336). [PDF]
Pontiroli AE +4 more
europepmc +1 more source
Introducción: La terapia de elección de los prolactinomas son los agonistas dopaminérgicos, cuyo principal exponente es la bromocriptina, sin embargo, hay pacientes que no responden o presentan severos efectos secundarios (resistentes o intolerantes a bromocriptina, respectivamente).
Francisco Javier Velázquez-Chávez +2 more
openaire +1 more source
[Anticholinergic burden in the elderly]. [PDF]
Rodríguez Casal M.
europepmc +1 more source
Ruolo della rapamicina nei pazienti sottoposti a trapianto di fegato che hanno sviluppato complicanze secondarie all'uso di farmaci inibitori della calcineurina [PDF]
Varotti, Giovanni <1972>
core +1 more source

